Cite
HARVARD Citation
Huang, A. et al. (2016). Epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors combined with chemotherapy in first‐line treatment in an advanced non‐small cell lung cancer patient with EGFR sensitive mutation. Thoracic cancer. 7 (5), pp. 614-618. [Online].